Panacea Biotech’s Baddi unit gets OAI status from USFDA

Source: CNBCTV18 Panacea Biotech informed the exchanges that the United States Food & Drug Administration (USFDA) has classified the company’s Baddi facility in Himachal Pradesh as an “Official Action Indicated” (OAI). The facility was issued a form-483 by the drug regulator with nine observations in October, which were related to improvements in existing procedures. An […]